Circulating matrix metalloproteinase-9 levels as a biomarker of disease [Carta] (2005)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; GERLACH, RAQUEL FERNANDA - FORP
- Unidades: FMRP; FORP
- Subjects: BIOMARCADORES; NEOPLASIAS; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2005
- Source:
- Título: Clinical Cancer Research
- ISSN: 1078-0432
- Volume/Número/Paginação/Ano: v. 11, p. 8887-8888, 2005
-
ABNT
GERLACH, Raquel Fernanda e TANUS-SANTOS, José Eduardo. Circulating matrix metalloproteinase-9 levels as a biomarker of disease [Carta]. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 jan. 2026. , 2005 -
APA
Gerlach, R. F., & Tanus-Santos, J. E. (2005). Circulating matrix metalloproteinase-9 levels as a biomarker of disease [Carta]. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Gerlach RF, Tanus-Santos JE. Circulating matrix metalloproteinase-9 levels as a biomarker of disease [Carta]. Clinical Cancer Research. 2005 ; 11 8887-8888.[citado 2026 jan. 26 ] -
Vancouver
Gerlach RF, Tanus-Santos JE. Circulating matrix metalloproteinase-9 levels as a biomarker of disease [Carta]. Clinical Cancer Research. 2005 ; 11 8887-8888.[citado 2026 jan. 26 ] - Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension
- Nicotine accutely increases plasma MMP-9 activity
- Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
